Alnylam Pharmaceuticals, Inc. · NASDAQ:ALNY
Vanguard Capital Management LLC reported a 5.35% stake in Alnylam Pharmaceuticals, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 29, 2026
Vanguard Capital Management LLC reported a 5.35% stake in Alnylam Pharmaceuticals, Inc., 7,104,536 shares, as a passive investor on Mar 31, 2026. Filed Apr 29, 2026 (Schedule 13G).
- Stake
- 5.35%
- Shares
- 7,104,536
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.35% | 7,104,536 |